Atria Wealth Solutions, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Atria Wealth Solutions, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$0.28 - $1.16 $1,050 - $4,350	-3,750 Reduced 11.47%	28,934 $9,000
Q1 2024 May 13, 2024	SELL	$1.06 - $1.67 $1,570 - $2,474	-1,482 Reduced 4.34%	32,684 $37,000
Q4 2023 Feb 02, 2024	BUY	$1.26 - $1.79 $1,399 - $1,988	1,111 Added 3.36%	34,166 $57,000
Q3 2023 Nov 08, 2023	BUY	$1.61 - $2.54 $24,254 - $38,265	15,065 Added 83.74%	33,055 $59,000
Q2 2023 Aug 03, 2023	BUY	$1.14 - $1.95 $4,560 - $7,800	4,000 Added 28.59%	17,990 $33,000
Q1 2023 Aug 22, 2023	SELL	$1.2 - $2.19 $4,800 - $8,760	-4,000 Reduced 22.23%	13,990 $18,000
Q4 2022 Aug 30, 2023	SELL	$1.63 - $3.52 $6,520 - $14,080	-4,000 Reduced 22.23%	13,990 $23,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $1,819 - $3,928	1,116 Added 8.67%	13,990 $23,000
Q3 2022 Feb 13, 2023	SELL	$0.73 - $3.74 $16,060 - $82,280	-22,000 Reduced 63.08%	12,874 $40,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $16,345 - $83,742	22,391 Added 179.37%	34,874 $92,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $27,462 - $52,428	12,483 New	12,483 $30,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.